Add Yahoo as a preferred source to see more of our stories on Google. The Bassett Healthcare Network has announced a regenerative and non-operative therapy for muscle, joint, and tendon injuries or ...

EVERY DAY FOR nearly 15 years, Raynie Canoy woke up in head-to-toe pain that made it hard to function. Her neck, back, and knees ached, and her hips felt so tight that some days she could barely bend ...

ROCHESTER, N.Y., Feb. 6, 2026 /PRNewswire/ -- What should patients understand before choosing PRP therapy as part of their treatment plan? The answer is outlined in a HelloNation article that explains ...

I have reached the beginning of osteoarthritis after a meniscus trim from years ago. Can platement-rich plasma (PRP) therapy, or anything else, regenerate cartilage? -- E.C. ANSWER: Loss of cartilage ...

Douglas Jantz, 57, a retired middle school teacher from Houston, has been playing tennis since he was 9. He is serious about his game, so he was worried when his knees started to hurt. Eventually, he ...

MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from ...

PHILADELPHIA (CBS) -- Running injuries are common. Many on Broad Street this weekend will be dealing with a variety of aches and pains. One emerging treatment involves using the patient's own blood.

MELBOURNE, Australia, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic ...

CINCINNATI (WKRC) - Local doctors are providing a pain-free solution for conditions ranging from tennis elbow to heel pain through a therapy known as platelet-rich plasma (PRP). The Christ Hospital ...

For patients living with chronic wounds, healing can begin to feel less like a process and more like a waiting game. Weeks turn into months, bandages are changed, instructions are followed, yet ...

“PRP may represent a true paradigm shift for pancreatic cancer patients,” said Mr. James Nathanielsz, Propanc’s Chief Executive Officer. “We’re striking at the disease’s core mechanisms. With Phase 1b ...